Back to top
more

InnovAge (INNV)

(Real Time Quote from BATS)

$6.29 USD

6.29
22,811

+0.22 (3.62%)

Updated Nov 6, 2024 11:50 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 45% (137 out of 251)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

InnovAge (INNV) delivered earnings and revenue surprises of 0% and 0.88%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Revvity (RVTY) delivered earnings and revenue surprises of 13.27% and 0.95%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

InnovAge Holding Corp. (INNV) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

InnovAge (INNV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

InnovAge Holding Corp. (INNV) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

InnovAge (INNV) delivered earnings and revenue surprises of 50% and 4.85%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

HealthEquity (HQY) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

HealthEquity (HQY) delivered earnings and revenue surprises of 22.86% and 5.43%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?

Patterson Cos. (PDCO) Lags Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Patterson Cos. (PDCO) delivered earnings and revenue surprises of -25% and 3.59%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?

Premier, Inc. (PINC) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Premier (PINC) delivered earnings and revenue surprises of 40.82% and 12.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of -4.17% and 5.13%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

InnovAge Holding Corp. (INNV) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of 0% and 4.07%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -100% and 3.21%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

InnovAge Holding Corp. (INNV) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -200% and 1.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

InnovAge Holding Corp. (INNV) Soars 15.4%: Is Further Upside Left in the Stock?

by Zacks Equity Research

InnovAge Holding Corp. (INNV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

HealthEquity (HQY) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

HealthEquity (HQY) delivered earnings and revenue surprises of 12.77% and 1.95%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?

LumiraDx Limited (LMDX) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

LumiraDx Limited (LMDX) delivered earnings and revenue surprises of -6.67% and 0.31%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

MDxHealth SA Sponsored ADR (MDXH) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

MDxHealth SA Sponsored ADR (MDXH) delivered earnings and revenue surprises of 6.25% and 10.58%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Should You Hold on to Teladoc Health (TDOC) Stock for Now?

by Zacks Equity Research

Teladoc Health's (TDOC) cash-generating abilities are boosted by the growing number of visits and memberships.

InnovAge Holding Corp. (INNV) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of 0% and 1.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

3 Medical Services Stocks to Buy Amid Industry Challenges

by Urmimala Biswas

The Zacks Medical - Services industry is growing on digital healthcare adoption. EMBC, INNV and OCX are set to gain the most. However, staffing shortages may disrupt the trend.

InnovAge Holding Corp. (INNV) Loses -7.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

by Zacks Equity Research

The heavy selling pressure might have exhausted for InnovAge Holding Corp. (INNV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

InnovAge Holding Corp. (INNV) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of 36.36% and 1.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

InnovAge Holding Corp. (INNV) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -150% and 1.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Agilon (AGL) delivered earnings and revenue surprises of -40% and 6.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Doximity (DOCS) Q2 Earnings Expected to Decline

by Zacks Equity Research

Doximity (DOCS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: InnovAge Holding Corp. (INNV) Q1 Earnings Expected to Decline

by Zacks Equity Research

InnovAge Holding Corp. (INNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.